Elevation Point Wealth Partners LLC Purchases New Shares in Danaher Corporation $DHR

Elevation Point Wealth Partners LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,125 shares of the conglomerate’s stock, valued at approximately $2,250,000.

Other institutional investors have also added to or reduced their stakes in the company. Sivia Capital Partners LLC lifted its holdings in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after acquiring an additional 119 shares during the period. First Trust Advisors LP grew its stake in Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after purchasing an additional 14,217 shares during the period. Main Street Financial Solutions LLC increased its position in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares during the last quarter. Ieq Capital LLC increased its position in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC raised its stake in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after purchasing an additional 325 shares during the period. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

DHR has been the subject of several research reports. Royal Bank Of Canada increased their price target on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Piper Sandler initiated coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Finally, Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Price Performance

Shares of NYSE:DHR opened at $219.42 on Monday. The firm has a market capitalization of $154.25 billion, a PE ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $195.80 and a two-hundred day moving average price of $192.40. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.77 earnings per share. Equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.